In this photo illustration, the Madrigal Pharmaceuticals logo is displayed on a smartphone screen. Rafael Henrique | SOPA Images | Lightrocket |
Tag: Eli Lilly and Co
Stocks making the biggest moves midday: NVDA, COIN, ORCL, BALY
Check out the companies making headlines in midday trading. Bally’s — Shares soared more than 25% after hedge fund Standard General made
Eli Lilly hits another Alzheimer’s hurdle. But obesity, diabetes GLP-1s strong
Eli Lilly ‘s experimental Alzheimer’s treatment hit another hurdle with U.S. drug regulators. It pushed out the timeline for potential approval but
Novo Nordisk Wegovy approved for cutting heart disease risks
Injection pens of Novo Nordisk’s weight-loss drug Wegovy are shown in this photo illustration in Oslo, Norway, Nov. 21, 2023. Victoria Klesty
Eli Lilly Alzheimer’s drug FDA approval delayed
Eli Lilly headquarters in Indianapolis, Indiana, US, on Wednesday, May 3, 2023. Eli Lilly & Co.’s shares climbed in early US trading
Cigna to cap insurance spending
Injection pens of Novo Nordisk’s weight-loss drug Wegovy are shown in this photo illustration in Oslo, Norway, Nov. 21, 2023. Victoria Klesty
Chip stocks soar — plus, this lagging industrial is due for a catch-up trade
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the
Novo Nordisk shares jump 5% on promising weight loss trial results; Eli Lilly dips
Jonathan Raa | Nurphoto | Getty Images Novo Nordisk shares climbed 5% on Thursday morning, according to LSEG data, hitting a fresh
Jim Cramer says get ready to buy if there’s a market sell-off
CNBC’s Jim Cramer on Monday disputed talk of sector bubbles, saying investors should be prepared to buy if there’s a sell-off and
Cramer says he really wants ‘everyone to own’ Coterra Energy
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of
No More Posts Available.
No more pages to load.